CDH1 and prostate cancer: SSX2 knockdown, in the 22Rv1 prostate cancer line, demonstrated a large fold change in many different EMT associated genes (TWIST1, ZEB2, MMP2, VIM, CDH1, CDH2) however these genes did not respond in an anticipated or canonical way (Figure 2E).